VANCOUVER, Oct. 1, 2018 /CNW/ - Zecotek Photonics
Inc. ("Zecotek" or the "Company") (TSX-V: ZMS)
(Frankfurt: W1I), a developer of leading-edge photonics
technologies for healthcare, industrial and scientific
markets, is pleased to announce that it has initiated the
manufacturing of its new generation series of solid-state
micro-pixel avalanche photo diodes and transistors (MAPD/T) at the
Malaysian Institute of Microelectronics Systems.
A portion of the funds raised in the divisional equity financing
announced in June 2018 have been
allocated to the manufacturing of the new generation series of
solid-state MAPD/T. The Company will move to full production and
commercialization to meet the increasing demand for medical
imaging, high-energy physics and other industrial applications
including an expected increase in joint sale with the LFS
scintillation crystal for advanced positron emission tomography
(PET) medical scanners.
"We are very pleased to have the Malaysian Institute of
Microelectronic Systems begin the production of our patented high
dynamic range photo detectors," said Dr. A.F. Zerrouk,
Chairman, President, and CEO of Zecotek Photonics Inc.
"This is the first phase to the commercialization of the new
generation series of solid-state MAPD/T before moving to full
production and commercialization. We are experiencing increased
demand from medical imaging, high energy physics and other
industrial sectors for applications such as LIDAR for electric and
self driven vehicles, due to the significant performance advantages
of our MAPD/T."
Zecotek's patented series of solid-state MAPD/T have been
modified to improve performance parameters and reduce the cost of
manufacture, and now offer significant performance-cost advantages
over competing photomultiplier tubes (PMT) and other solid-state,
silicon-based photo detectors known as SiPM. Recent changes have
reduced the manufacturing cost and improved timing resolution and
photon detection efficiency - key characteristics for the new
configurations of high resolution PET medical scanners. The
solid-state MAPD/T also offer superior recovery time, unique
radiation hardness and display of the highest possible linearity,
making them prime components for the improved detector designs
required in high energy experiments at the Chinese Institute of
High Energy Physics (IHEP) and CERN.
Also reported, as part of the recently announced strategic
review undertaken by the board of directors and senior management
of the Company, each subsidiary of the Company has been tasked to
enhance their intellectual property portfolio to target those
markets with immediate needs in fast growing industries. This
review has identified new and exciting applications for the
solid-state MAPD/T in emerging industries such as self-driving
automobiles, agriculture and genomics.
Autonomous Automobiles
Self-driving cars rely on light detection and ranging (LIDAR)
units composed of photosensors. Zecotek's solid-state MAPT
photosensors have extremely high resolution with single photon
detection, making it an obvious component in the new LIDAR
configurations. Zecotek AutoTronics is developing a proprietary
LIDAR unit.
Agriculture
In agriculture, quality control of micro-active elements is key
to maintaining the level of potency and nutritional content as
advertised and advised for consumption. Zecotek's high-resolution
MAPT photosensors combined with other proprietary photonic
technologies can play a central role in measurement devices that
define and measure the efficacy of extraction of useful elements
from various plants, vegetables and fruits.
Genomics
The interdisciplinary field of science focusing on the
structure, function, evolution, mapping, and editing of genomes,
has been identified by Zecotek Imaging System as an opportune and
ready market. Genomics evolved from a series of experimental and
conceptual advances that allowed researchers to decipher the DNA
sequences of whole genomes from virtually any organism and
Zecotek's MAPD/T are components that can play a significant role in
this important field.
About Malaysian Institute of Microelectronic
Systems
MIMOS is Malaysia's premier
Applied Research and Development Centre in Information and
Communications Technology, Industrial Electronics Technology and
Nano-Semiconductor Technology. As a strategic agency under the
Ministry of Science, Technology and Innovation (MOSTI), MIMOS
contributes to raising Malaysia's
competitiveness by pioneering market creation for Malaysian
technopreneurs through patentable technology platforms, products
and solutions. Over the past 12 years, MIMOS has filed more than
2,000 Intellectual Properties in various technology domains and
across key socio-economic areas. Serving a central role in
Malaysia's transformation journey
and ICT Vision, MIMOS endeavors to create a culture of innovation
by nurturing relationships with internal and external stakeholders,
in the spirit of smart partnerships and inclusive growth models and
strategies.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS) (Frankfurt: W1I) (OTCPK:
ZMSPF) is a photonics technology company developing
high-performance scintillation crystals, photo detectors, positron
emission tomography scanning technologies, 3D auto-stereoscopic
displays, 3D metal printing, and lasers for applications in
medical, high-tech and industrial sectors. Founded in 2004, Zecotek
operates three divisions: Imaging Systems, Optronics Systems and 3D
Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances with Hamamatsu Photonics (Japan), the European Organization for Nuclear
Research (Switzerland), Shanghai
EBO Optoelectronics Technology Co. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit http://www.zecotek.com and follow @zecotek on
Twitter.
This press release may contain forward-looking statements
that are based on management's expectations,
estimates, projections and assumptions. These statements are not
guarantees of future performance and involve certain risks
and uncertainties, which are difficult to predict. Therefore,
actual future results and trends may differ materially from what
may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at http://www.zecotek.com
SOURCE Zecotek Photonics Inc
